Research News

The new class of LRF Scholars is pursuing research projects covering a diverse range of lymphoma subtypes with a goal to improve patient outcomes.

Dr. Kara Kelly is helping to build the bridge between AYA, and pediatric and adult oncology fields to bring attention to this underserved population and improve patient care.

The Lymphoma Research Foundation (LRF) is proud to announce it has awarded 16 grants totaling…

The Lymphoma Research Foundation (LRF) returned to the American Society of Hematology (ASH) Annual Meeting and Exposition, with nearly 70 LRF-affiliated scientists presenting more than 100 abstracts at this year’s conference.

Playing the long game is not a new concept for Lymphoma Research Foundation Grantee and Scientific Advisory Board (SAB) member Ari Melnick, MD, of NewYork-Presbyterian/Weill Cornell Medicine. Lymphoma research is not a field for those looking for instant gratification, but Dr. Melnick has never taken a sprinter’s approach to finding cures for lymphoma. He is more of a marathoner.

A study partially funded by the Lymphoma Research Foundation, and published in the Journal of Experimental Medicine, revealed surprising new functions for a protein called MYC.

Several oral agents have been proven active in the treatment of certain subtypes of non-Hodgkin…

In a study funded in part by the Lymphoma Research Foundation, researchers find the loss…

Rituximab (Rituxan) has long been the standard of care for many lymphoma patients with relapsed…

At the 2018 ASH Annual Meeting, Catherine Diefenbach, MD (New York University) – a past…